Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Summary

This is a multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of ITI-1284 as monotherapy treatment in patients meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) criteria for GAD in patients who have had inadequate response to generalized anxiety disorder treatment.

Timeline

Start

2024-11-21

Primary completion

2027-06

Completion

2027-06

Drugs

Indications